公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment | Wang P.-H.; Pan S.-W.; CHIN-CHUNG SHU ; CHUNG-YU CHEN ; Wei Y.-F.; Cheng S.-L.; HAO-CHIEN WANG ; CHONG-JEN YU | Respiratory Medicine | 9 | 7 | |
2019 | Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study | YUNG-HSUAN CHEN ; YEN-FU CHEN ; CHUNG-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | BMC Cancer | 16 | 11 | |
2020 | Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer | CHUNG-YU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of the Formosan Medical Association | 5 | 4 | |
2020 | Clinical features and treatment outcomes of Mycobacterium chimaera lung disease and antimicrobial susceptibility of the mycobacterial isolates | LUN-CHE CHEN ; Huang H.-N.; CHONG-JEN YU ; JUNG-YIEN CHIEN ; PO-REN HSUEH | Journal of Infection | 8 | 5 | |
2003 | Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a University Hospital in Taiwan | LU-CHENG KUO ; CHONG-JEN YU ; LI-NA LEE ; Wang J.-L.; HAO-CHIEN WANG ; PO-REN HSUEH ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 43 | 33 | |
2017 | Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008–2014 | MENG-RUI LEE ; JUNG-YIEN CHIEN ; YU-TSUNG HUANG ; Liao C.-H.; CHIN-CHUNG SHU ; CHONG-JEN YU ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 12 | 8 | |
2014 | Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer | Pallaud C.; Reck M.; Juhasz E.; Szima B.; CHONG-JEN YU ; Burdaeva O.; Orlov S.; Hilton M.; Archer V.; Mok T. | Lung Cancer | 18 | 16 | |
2004 | Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients | JANN-TAY WANG ; WANG-HUEI SHENG ; CHI-TAI FANG ; YEE-CHUN CHEN ; Wang J.-L.; CHONG-JEN YU ; SHAN-CHWEN CHANG ; PAN-CHYR YANG | Emerging Infectious Diseases | 184 | 161 | |
2023 | Clinical outcomes and risk factors of progressive pulmonary fibrosis in primary Sjögren's syndrome-associated interstitial lung disease | YU-HSUAN CHEN ; Lee, Tai-Ju; Hsieh, Hsin-Jung; SONG-CHOU HSIEH ; HAO-CHIEN WANG ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; JUNG-YIEN CHIEN | BMC pulmonary medicine | 3 | 1 | |
2019 | Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations | YEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | International Journal of Cancer | 53 | 46 | |
2020 | Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer | WEN-CHI YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; ZHONG-ZHE LIN ; Lu S.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Clinical and Translational Radiation Oncology | 11 | 8 | |
2012 | Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR | KUEI-PIN CHUNG ; SHANG-GIN WU ; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Clinical Cancer Research | 60 | 55 | |
2008 | Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer | Chen C.-H.; Gow C.-H.; CHONG-JEN YU ; JIN-YUAN SHIH ; Hsu Y.-C.; Lee W.-Y.; PAN-CHYR YANG ; Kuo S.-H. | Journal of Cancer Molecules | 8 | | |
2009 | Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients | CHUN-TA HUANG ; Tsai Y.-J.; CHIN-CHUNG SHU ; Lei Y.-C.; JANN-YUAN WANG ; CHONG-JEN YU ; LI-NA LEE ; PAN-CHYR YANG ; the TAMI Group | Respiratory Medicine | 28 | 26 | |
2024 | Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients | TING-YU LIAO ; YU-TSUNG HUANG ; Lee, Tai-Fen; PO-REN HSUEH ; CHONG-JEN YU ; JUNG-YIEN CHIEN | International journal of antimicrobial agents | | | |
2019 | The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease | CHIN-CHUNG SHU ; Pan, Sheng-Wei; Feng, Jia-Yih; JANN-YUAN WANG ; Chan, Yu-Jiun; CHONG-JEN YU ; Su, Wei-Juin | Journal of clinical medicine | 21 | 20 | |
2012 | Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment | KUEI-PIN CHUNG ; Huang Y.-T.; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; YEUN-CHUNG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Chest | 44 | 42 | |
2000 | Clinical spectrum of acute respiratory distress syndrome in a tertiary referral hospital: Etiology, severity, clinical course, and hospital outcome | JIH-SHUIN JERNG ; CHONG-JEN YU ; Liaw Y.-S.; HUEY-DONG WU ; HAO-CHIEN WANG ; PING-HUNG KUO ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 6 | 5 | |
1995 | Clinical Spectrum of Tuberculosis in Older Patients | Liaw Y. S.; PAN-CHYR YANG ; CHONG-JEN YU ; Wu Z. G.; Chang D. B.; LI-NA LEE ; Kuo S. H.; KWEN-TAY LUH | Journal of the American Geriatrics Society | 44 | 36 | |
2019 | Clinical Trajectories and Causes of Death in Septic Patients with a Low APACHE II Score | CHUN-TA HUANG ; SHENG-YUAN RUAN ; Tsai, Yi-Ju; SHIH-CHI KU ; CHONG-JEN YU | Journal of clinical medicine | 15 | 13 | |